Fredun Pharmaceuticals Ltd - 539730 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Fredun Pharmaceuticals Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.06-02-2019
06-02-2019
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose herewith the copies of the Notice of the ensuing Board Meeting of the Company scheduled to be held on Monday, February 11, 2019; published in Business Standard & Mumbai Lakshadeep newspaper on February 2, 2019.04-02-2019
Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Intimation Of The 170Th Board Meeting
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2019 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the Quarter ended December 30, 201801-02-2019
Fredun Pharmaceuticals Ltd - 539730 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Fredun Pharmaceuticals Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.28-01-2019
Fredun Pharmaceuticals Ltd - 539730 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fredun Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here14-01-2019
Fredun Pharmaceuticals Ltd - 539730 - Voting Results Of Postal Ballot
In compliance to Regulation 44(3) of SEBI Listing Regulations, 2015; we hereby submit the Voting Results of the business transacted by the Postal Ballot of the Company, along with the Scrutinizers Report as issued by Mr. Rajendra R. Vaze of M/s. Rajendra & Co., Practising Company Secretaries.12-01-2019
Fredun Pharmaceuticals Ltd - 539730 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Priyanka ChaturvediDesignation :- Company Secretary and Compliance Officer09-01-2019
Fredun Pharmaceuticals Ltd - 539730 - Shareholding for the Period Ended December 31, 2018
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here09-01-2019
Fredun Pharmaceuticals Ltd - 539730 - Receipt Of Award
We are happy to share with our stakeholders that the Company has received a Prestigious and a well-recognized award in the Pharma Sector 'Pharma Leaders Most Promising and Dynamic Company of the Year 2018' at Pharma Leaders Power Brand Awards 2018 presented to the Company on Wednesday, December 19, 201822-12-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith the copies of newspaper advertisement published on Wednesday, December 12, 2018 in Business Standard (English) and Mumbai Lakshadeep (Marathi); informing the shareholders about the dispatch of Postal Ballot Notice dated December 5, 2018.12-12-2018